biostrategics.wordpress.com
BioStrategics Consulting Ltd Blog | A Clinical Development Blog SiteA Clinical Development Blog Site
http://biostrategics.wordpress.com/
A Clinical Development Blog Site
http://biostrategics.wordpress.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
2.6 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
26
SITE IP
192.0.78.12
LOAD TIME
2.612 sec
SCORE
6.2
BioStrategics Consulting Ltd Blog | A Clinical Development Blog Site | biostrategics.wordpress.com Reviews
https://biostrategics.wordpress.com
A Clinical Development Blog Site
biostrategics.wordpress.com
BioStrategics Consulting Ltd | BioStrategics Consulting Ltd Blog
https://biostrategics.wordpress.com/author/biostrategics
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. Author Archives: BioStrategics Consulting Ltd. About BioStrategics Consulting Ltd. BioStrategics Consulting Ltd provides a range of management-level clinical development consulting services to the pharmaceutical and biotechnology industries. Clinical Trial Probability of Success? Just How Probable Is A Great Outcome. June 27, 2011. Clinical Trial Success: How Do You Define Success? June 20, 2011. June 13, 2011.
Clinical Trial Probability of Success? Just How Probable Is A Great Outcome. | BioStrategics Consulting Ltd Blog
https://biostrategics.wordpress.com/2011/06/27/clinical-trial-probability-of-success-just-how-probable-is-a-great-outcome
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. Clinical Trial Success: How Do You Define Success? Clinical Trial Probability of Success? Just How Probable Is A Great Outcome. June 27, 2011. The cost and time of well-designed clinical trials is growing rapidly, but just how probable is it that the data will be sufficient to support regulatory approval and market success? Were reported as follows:. Stage of Development Probability of Approval. In the larger...
Latest News | BioStrategics Consulting Ltd Blog
https://biostrategics.wordpress.com/latest-news-biostrategics-consulting-ltd
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. June 27 Clinical Trial Probability of Success? Just How Probable Is A Great Outcome. June 20 Clinical Trial Success: How Do You Define Success? June 13 CLINICAL DEVELOPMENT: CLINICAL TRIAL DATA MANAGEMENT, STATISTICAL PROGRAMMING AND ANALYSIS, AND QUALITY ASSURANCE. June 6 CLINICAL DEVELOPMENT: THE CLINICAL TRIAL CASE REPORT FORM AND CLINICAL TRIAL MONITORING. May 30 Ensuring Clinical Trial Data Quality.
Testimonials | BioStrategics Consulting Ltd Blog
https://biostrategics.wordpress.com/biostrategics-consulting-ltd-testimonials
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. Sr Director Clinical Operations, Eisai Pharmaceuticals (formerly MGI Pharma, INC.), Lexington, MA. CEO, Innate Therapeutics:. CEO Can Fite BioPharma. Mike is an excellent partner. We would hire him again in a heartbeat. He integrates science, medicine, regulatory demands and business strategy as a corporate officer should. He is well organized and defines clear goals. Previously CEO at Zycos. Enter your email...
BioStrategics Services | BioStrategics Consulting Ltd Blog
https://biostrategics.wordpress.com/biostrategic-consulting-ltd-services
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. BioStrategics Consulting Ltd offers the following clinical development consulting services to pharmaceutical, biotechnology, and medical device companies:. Clinical program strategy and planning. IND and first-in-man trial planning. Clinical protocol conceptualization and creation. Identification of, and interaction with, prospective investigators and academic thought-leaders. Leave a Reply Cancel reply.
TOTAL PAGES IN THIS WEBSITE
6
BioProcess Blog » Conference announcement
http://www.bioprocessblog.com/archives/category/conference-announcement
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Posted by Al Doig Under Biopharmaceuticals. Monday Jun 20, 2016. No Comments ». Emerging Bio-Therapies and Their Manufacturing Challenges – BIO 2016. Posted by Al Doig Under Antibody drug conjugates. Friday May 20, 2016. Emerging Bio-Therapies and Their Manufacturing Challenges.
BioProcess Blog » Home
http://www.bioprocessblog.com/index-php
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! This is an example of a WordPress page, you could edit this to put information about yourself or your site so readers know where you are coming from. You can create as many pages like this one or sub-pages as you like and manage all of your content inside of WordPress.
BioProcess Blog » Outsourcing
http://www.bioprocessblog.com/archives/category/outsourcing
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! American Biomanufacturing Summit 2016. Posted by Al Doig Under Biopharmaceuticals. Monday Apr 4, 2016. Discussing strategic capacity issues when building a global network. Planning for variability in market demand for both mature and a growing products. The other panelists are:.
BioProcess Blog » Manufacturing facilities
http://www.bioprocessblog.com/archives/category/manufacturing-facilities
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Top 3 COGS Drivers for Peptide Therapeutics. Posted by Julia Adam Under Cost of Goods (COGS). Wednesday Nov 11, 2015. By Terence Davidovits ( tdavidovits. Recently synthesized IL-10, consisting of 160 amino acids. The FDA. As outlined in a previous BPTC blog. No Comments ». 27 of 30...
BioProcess Blog » Process development
http://www.bioprocessblog.com/archives/category/process-development
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Quality by Design (QbD): Seeing the Glass as Half Full. Posted by Al Doig Under Biopharmaceuticals. Wednesday Aug 10, 2016. Edition of The Development of Therapeutic Monoclonal Antibody Products. Due to publish in September 2016, provides extensive coverage of QbD as applied through...
BioProcess Blog » EMA
http://www.bioprocessblog.com/archives/category/ema
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! The BIO International Convention. Posted by Julia Adam Under Cell therapy. Cost of Goods (COGS). Sunday Jun 7, 2015. Join BPTC at the annual BIO International Convention. Email us ( jadam. To discuss your immediate needs now! No Comments ». Thursday Jan 29, 2015. It became apparent ...
BioProcess Blog » Cost of Goods (COGS)
http://www.bioprocessblog.com/archives/category/cost-of-goods-cogs
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Opportunities for Continuous Manufacturing in Biopharmaceutical Production. Posted by Al Doig Under Biopharmaceuticals. Cost of Goods (COGS). Monday Jun 27, 2016. No Comments ». Top 3 COGS Drivers for Peptide Therapeutics. Posted by Julia Adam Under Cost of Goods (COGS). A current a...
BioProcess Blog » Manufacturing capacity
http://www.bioprocessblog.com/archives/category/manufacturing-capacity
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! BIO International Convention 2016. Posted by Al Doig Under Biopharmaceuticals. Wednesday May 11, 2016. BIO International Convention 2016. San Francisco, CA. Join BPTC at the annual BIO International Convention 2016. No Comments ». American Biomanufacturing Summit 2016. Discussing st...
BioProcess Blog » Manufacturing efficiency
http://www.bioprocessblog.com/archives/category/manufacturing-efficiency
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Top 3 COGS Drivers for Peptide Therapeutics. Posted by Julia Adam Under Cost of Goods (COGS). Wednesday Nov 11, 2015. By Terence Davidovits ( tdavidovits. Recently synthesized IL-10, consisting of 160 amino acids. The FDA. As outlined in a previous BPTC blog. No Comments ». To discu...
BioProcess Blog » Modeling
http://www.bioprocessblog.com/archives/category/modeling
Trends and issues in biopharmaceutical development. Subscribe to our RSS Feed. Cost of Goods (COGS). Process Performance Qualification (PPQ). Target Product Profile (TPP). BPTC 's blogroll. Events are coming soon, stay tuned! Can we have it all? The quest for quality, cost and speed in Biopharma. Posted by Julia Adam Under Conference announcement. Cost of Goods (COGS). Wednesday Jun 10, 2015. By Al Doig ( adoig. And Tom Ransohoff ( transohoff. Process analytical technologies, and novel facilities concepts.
TOTAL LINKS TO THIS WEBSITE
26
Home
A gLOBAL lEADER IN MANAGEMENT Consulting FOR THE LIFE SCIENCE INDUSTRIES. Welcome to BioStrat, your strategic partner for success. We serve the innovative life science industries and their investors. Our clients are faced with more challenges than ever in areas such as pricing and market access, internal productivity and business model, competitive dynamics, and evolving medical practice and patient needs. That’s what we are here for. BioStrat is a different kind of strategy consulting firm. BioStrat fou...
BioStrata - The Specialist Life Science Marketing Agency
Cookie & Privacy Policy. Public Relations & Social Media. Strategy & Planning. News & Blog. Life Science Marketing Services. As a specialist marketing agency working in life science, our team is fluent in the languages of science and business. We combine PhD level knowledge with decades of marketing experience to offer marketing services, inbound marketing and integrated programmes that deliver results for life science companies. Need to create your plan? Capture and nurture leads? Then get in touch.
Mission
Est une société indépendante proposant aux acteurs du secteur des Sciences du Vivant et de la Santé des services et des outils de décision adaptés pour optimiser la CREATION DE VALEUR. Autour des technologies et des actifs. Rassemblée autour de valeurs essentielles et animée par la culture du résultat, l’équipe de BSP. Proactivité et anticipation positionnent BSP. Comme un allié privilégié et durable des acteurs de ce secteur complexe. L’exécution des missions confiées à BSP. Nous nous projetons dans l’a...
biostrategic-research.com
Ce nom de domaine n'est pas disponible. Il a été enregistré via gandi.net. More information about the owner. Enregistrer votre nom de domaine. Chez Gandi, vous avez le choix sur plus d'une centaine d'extensions et vous bénéficiez de tous les services inclus (mail, redirection, ssl.). Rechercher un nom de domaine. Votre site dans le cloud? Découvrez Simple Hosting, notre cloud en mode PaaS à partir de 4 HT par mois (-50% la première année pour les clients domaine). It is currently being parked by the owner.
Biostrategics - Home
Setting the Curve in Consulting to the Biopharmaceutical Industry. About Dr. Silverman. Clinical and Clinical/Regulatory Operations. Business Strategic Analysis and Planning. Technical Assessment and Recommendations. BioStrategics Consulting Ltd, through its Founder and President Michael Silverman, MD, FACP,. Provides a range of management-level clinical development consulting services to the pharmaceutical and biotechnology industries, including:. IND planning and preparation. Numerous first-in-man clin...
BioStrategics Consulting Ltd Blog | A Clinical Development Blog Site
BioStrategics Consulting Ltd Blog. A Clinical Development Blog Site. About Dr Michael Silverman. Clinical Trial Probability of Success? Just How Probable Is A Great Outcome. June 27, 2011. The cost and time of well-designed clinical trials is growing rapidly, but just how probable is it that the data will be sufficient to support regulatory approval and market success? The statistics are staggering. In 2007, Morgan Stanley estimated that to end up with one drug in the market. Were reported as follows:.
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
BioStrategies-LC
2014 Research Initiative Grant. Biostrategies LC got a grant by the National Tay-Sachs and Allied Diseases Association (NTSAD): Lectin-assisted transnasal delivery of corrective enzyme for GM1 gangliosidosis. BioStrategies LC wins National 2012 Tibbetts Award for Being Among Best US Small Technology Firms Funded by SBIR Grants. Rare disease therapeutics development is a major focus of R&D at BioStrategies LC. BioStrategies LC at ABI.
bioStrategies Group
BioStrategies Group offers commercialization strategies to all sectors of the biopharma industry. Our team provides strategic, incisive and timely recommendations that are based on in-depth product-level analysis, guided by quantitative analytics and delivered with a board-level perspective. We bring a unique set of skills to the evaluation of complex commercial issues in the U.S. and global health care markets. Learn more ». How can we help you? How can we help you? Latest Insights Feb 12, 2015.
Biostrategis --- A catalyst for success --- Un catalyseur de succès
La version française du site est présentement en construction.
Samani Marions Panyaught Consultancy, NYC
CONTACT: Vasos Panagiotopoulos,. Strategy Consultant (Bio and Math Firms),. Samani Marions Panyaught Consultancy. Focuses on biotechnology, medical devices, and heavily mathematical software. Trained in bio-fluid mechanics and innovation management. Former Columbia Bioengineering Research Assistant for Prof Richard Skalak. Formerly advised restructuring of Columbia MBA Technology Management course. Former NY Federal Reserve Analyst. Samani was founded in 1977. Providing advisory and liaison services in:.
SOCIAL ENGAGEMENT